# DICLOFENAC POTASSIUM
> **ANDA215375** · Abbreviated New Drug Application (Generic) · Sponsor: ANNORA PHARMA · Approved 2022-03-04
## Drug
- **FDA Application Number:** ANDA215375
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DICLOFENAC POTASSIUM
- **Generic name:** DICLOFENAC POTASSIUM
- **Active ingredients:** DICLOFENAC POTASSIUM
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ANNORA PHARMA
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2022-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215375)
---
*MORVS · CC0 1.0*